Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Tagoor Lab Vildagliptin

    Virtual Booth

    Contact Supplier

    Vildagliptin

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Vildagliptin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 502Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Acquired approval for manufacturing and marketing generic drugs
    Acquired approval for manufacturing and marketing generic drugs

    15 Aug 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/release240815.pdf

    PRESS RELEASE
    15 Aug 2024
    Share Share
    Tiefenbacher Successfully Launches Generic Version Diabetis Med Vildagliptin
    Tiefenbacher Successfully Launches Generic Version Diabetis Med Vildagliptin

    08 Sep 2022

    // PRESS RELEASE

    https://tiefenbachergroup.com/2022/09/08/new-market-launch-tiefenbacher-pharmaceuticals-successfully-launches-generic-version-of-the-diabetis-medicine-vildagliptin-and-vildagliptin-metformin-in-africa/

    PRESS RELEASE
    08 Sep 2022
    Share Share
    Accord Healthcare Vildagliptin/Metformin HCL Receives Approval in Europe
    Accord Healthcare Vildagliptin/Metformin HCL Receives Approval in Europe

    17 Jun 2022

    // EMA

    https://www.ema.europa.eu/en/documents/overview/vildagliptin/metformin-hydrochloride-accord-epar-medicine-overview_en.pdf

    EMA
    17 Jun 2022
    Share Share
    Glenmark Pharma launches FDC drug for type 2 diabetes
    Glenmark Pharma launches FDC drug for type 2 diabetes

    26 Oct 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=143498&sid=2

    PHARMABIZ
    26 Oct 2021
    Share Share
    Glenmark becomes the first company to launch Remogliflozin + Vildagliptin
    Glenmark becomes the first company to launch Remogliflozin + Vildagliptin

    29 Dec 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/in/news-releases/glenmark-becomes-the-first-company-to-launch-remogliflozin-vildagliptin-fixed-dose-combination-at-an-affordable-price-for-adults-with-type-2-diabetes-in-india-821947177.html

    PRNEWSWIRE
    29 Dec 2020
    Share Share
    Cipla acquires brand, trademark for anti-diabetic drug Vysov in India
    Cipla acquires brand, trademark for anti-diabetic drug Vysov in India

    16 Dec 2019

    // BUSINESS-STANDARD

    https://www.business-standard.com/article/pti-stories/cipla-acquires-brand-trademark-rights-for-for-anti-diabetic-drug-vysov-in-india-119121600877_1.html

    BUSINESS-STANDARD
    16 Dec 2019
    Share Share